
Very good post about the economics of and investor dynamics in drug discovery/biotech/techbio startups, where the hard problems are, and the fundamental challenges in assessing outcomes and quality.
With the start of my first batch as a visiting partner at @ycombinator, this felt like a good time to write my founder story about our journey at @reverielabs. It's a bit of a long one. ankitg.me/blog/2025/01/06/un…



























